Viemed Healthcare (VMD) Projected to Post Earnings on Tuesday
by Amy Steele · The Cerbat GemViemed Healthcare (NASDAQ:VMD – Get Free Report) will likely be releasing its Q1 2026 results after the market closes on Tuesday, May 5th. Analysts expect Viemed Healthcare to post earnings of $0.09 per share and revenue of $74.40 million for the quarter. Interested persons may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 11:00 AM ET.
Viemed Healthcare (NASDAQ:VMD – Get Free Report) last posted its quarterly earnings data on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.02. The company had revenue of $76.18 million during the quarter, compared to analyst estimates of $77.70 million. Viemed Healthcare had a net margin of 5.53% and a return on equity of 10.72%. On average, analysts expect Viemed Healthcare to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Viemed Healthcare Stock Performance
NASDAQ VMD opened at $9.97 on Friday. The firm has a market cap of $383.65 million, a price-to-earnings ratio of 26.95 and a beta of 1.15. The company has a 50 day moving average of $9.31 and a 200-day moving average of $7.93. The company has a current ratio of 1.18, a quick ratio of 1.06 and a debt-to-equity ratio of 0.08. Viemed Healthcare has a 1-year low of $5.93 and a 1-year high of $10.18.
Insider Activity at Viemed Healthcare
In other news, President Michael Moore sold 65,000 shares of the stock in a transaction that occurred on Friday, March 20th. The shares were sold at an average price of $8.77, for a total transaction of $570,050.00. Following the sale, the president directly owned 1,585,812 shares of the company’s stock, valued at $13,907,571.24. This represents a 3.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders have sold 136,802 shares of company stock worth $1,237,976 over the last quarter. 20.00% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Viemed Healthcare
Hedge funds and other institutional investors have recently bought and sold shares of the business. Kemnay Advisory Services Inc. bought a new position in Viemed Healthcare in the fourth quarter valued at approximately $46,000. Quarry LP bought a new position in Viemed Healthcare in the third quarter valued at approximately $48,000. AQR Capital Management LLC bought a new position in Viemed Healthcare in the first quarter valued at approximately $90,000. MetLife Investment Management LLC boosted its stake in Viemed Healthcare by 52.7% in the fourth quarter. MetLife Investment Management LLC now owns 18,565 shares of the company’s stock valued at $138,000 after acquiring an additional 6,408 shares during the last quarter. Finally, Invesco Ltd. boosted its stake in Viemed Healthcare by 25.5% in the second quarter. Invesco Ltd. now owns 18,652 shares of the company’s stock valued at $129,000 after acquiring an additional 3,795 shares during the last quarter. 74.24% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on VMD. Wall Street Zen raised shares of Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 14th. Zacks Research raised shares of Viemed Healthcare to a “hold” rating in a research note on Thursday, January 8th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock has a consensus rating of “Hold”.
Read Our Latest Stock Analysis on VMD
Viemed Healthcare Company Profile
Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.
Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.